← Leaderboards
Grace M. Aldrovandi
University Of California Los Angeles
$132,783,121
Attributed
$137,540,192
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $20.8M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$137,540,192 · 10
By mechanism
UM1$123,715,670 · 2
R01$12,508,778 · 5
P30$864,213 · 2
R21$451,531 · 1
Top collaborators
- Louise Kuhn5 shared
- Christine Jennifer Mcgrath5 shared
- Peter A Anton4 shared
- Louis D Falo1 shared
- Andrea Gambotto1 shared
- Charles R Rinaldo1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Jimmy Kuang-Hsien Hu$2,908,850
- Sotirios Tetradis$9,598,114
- George T.j Huang$2,695,361
- Cun-Yu Wang$42,747,305
- Elizabeth R Sowell$36,362,090
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsInfectionInnovationPathogenesisPreventionClinical TrialsLaboratoriesChildSpecimenLaboratory StudyResearch PersonnelEvaluationTransmission ProcessHiv InfectionsPharmacologyClinical ResearchInfantAffectLeadershipVertical Disease TransmissionBaseImmunologyTotal Quality ManagementMorbidity - Disease Rate
Grant awards (64)
AIDS Clinical Trial Group Laboratory Center$14,702,977
UM1 · FY2025 · AI · contact PI
International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network$4,498,124
UM1 · FY2025 · AI · contact PI
AIDS Clinical Trial Group Laboratory Center$766,819
UM1 · FY2025 · AI · contact PI
AIDS Clinical Trial Group Laboratory Center$681,736
UM1 · FY2025 · AI · contact PI
Core C -Centralized Laboratory Support Core$177,031
P30 · FY2025 · AI · contact PI
AIDS Clinical Trial Group Laboratory Center$8,402,538
UM1 · FY2024 · AI · contact PI
International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network$4,359,227
UM1 · FY2024 · AI · contact PI
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trials$2,030,835
UM1 · FY2024 · AI · contact PI
Core C -Centralized Laboratory Support Core$165,969
P30 · FY2024 · AI · contact PI
AIDS Clinical Trial Group Laboratory Center$8,196,518
UM1 · FY2023 · AI · contact PI
International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network$4,534,929
UM1 · FY2023 · AI · contact PI
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants$742,388
R01 · FY2023 · HD
Core C -Centralized Laboratory Support Core$189,973
P30 · FY2023 · AI · contact PI
AIDS Clinical Trial Group Laboratory Center$1
UM1 · FY2023 · AI · contact PI
AIDS Clinical Trial Group Laboratory Center$8,265,554
UM1 · FY2022 · AI · contact PI
Study of Tecovirimat for Human Monkeypox Virus (STOMP)$5,882,075
UM1 · FY2022 · AI · contact PI
International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network$3,664,376
UM1 · FY2022 · AI · contact PI
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants$697,103
R01 · FY2022 · HD
Core C -Centralized Laboratory Support Core$188,482
P30 · FY2022 · AI · contact PI
AIDS Clinical Trial Group Laboratory Center$7,765,554
UM1 · FY2021 · AI · contact PI
International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network$3,548,875
UM1 · FY2021 · AI · contact PI
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants$704,283
R01 · FY2021 · HD
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3$5,798,868
UM1 · FY2020 · AI · contact PI
A5401 COVID Supplement$3,770,048
UM1 · FY2020 · AI · contact PI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center$3,092,246
UM1 · FY2020 · AI · contact PI
Clinical evaluation of SARS-CoV-2 subunit vaccine in a Phase I human clinical study$1,225,641
UM1 · FY2020 · AI · contact PI
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants$708,574
R01 · FY2020 · HD
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents$570,239
R01 · FY2020 · AI · contact PI
Breast Milk and COVID-19$292,406
UM1 · FY2020 · AI · contact PI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3$6,927,620
UM1 · FY2019 · AI · contact PI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center$3,522,734
UM1 · FY2019 · AI · contact PI
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants$767,313
R01 · FY2019 · HD
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents$593,733
R01 · FY2019 · AI · contact PI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3$6,586,951
UM1 · FY2018 · AI · contact PI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center$3,364,213
UM1 · FY2018 · AI · contact PI
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents$582,527
R01 · FY2018 · AI · contact PI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center$3,312,665
UM1 · FY2017 · AI · contact PI
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents$632,229
R01 · FY2017 · AI · contact PI
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center$1,780,794
UM1 · FY2016 · AI · contact PI
LC - IMPAACT Leadership Group$1,225,138
UM1 · FY2016 · AI · contact PI
LC - IMPAACT Leadership Group$2,823,246
UM1 · FY2015 · AI · contact PI
LC - IMPAACT Leadership Group$2,692,962
UM1 · FY2014 · AI · contact PI
Oral Transmission of HIV through Breastfeeding$275,293
R01 · FY2013 · DE
Oral Transmission of HIV through Breastfeeding$355,679
R01 · FY2012 · DE
Oral Transmission of HIV through Breastfeeding$193,190
R01 · FY2012 · DE
Pathogenesis of Mother to Child Transmission of HIV$570,501
R01 · FY2011 · HD · contact PI
Oral Transmission of HIV through Breastfeeding$440,668
R01 · FY2011 · DE
Pathogenesis of Mother to Child Transmission of HIV$574,375
R01 · FY2010 · HD · contact PI
Oral Transmission of HIV through Breastfeeding$412,462
R01 · FY2010 · DE
Pathogenesis of Mother to Child Transmission of HIV$570,518
R01 · FY2009 · HD · contact PI
Pathogenesis of Mother to Child Transmission of HIV$562,600
R01 · FY2008 · HD · contact PI
Pathogenesis of Mother to Child Transmission of HIV$574,117
R01 · FY2007 · HD · contact PI
Immunologic Effects of Lactation on HIV infected women$223,081
R21 · FY2006 · HD · contact PI
Pathogenesis of Mother to Child Transmission of HIV$448,204
R01 · FY2005 · HD
Immunologic Effects of Lactation on HIV infected women$228,450
R21 · FY2005 · HD
Pathogenesis of Mother to Child Transmission of HIV$437,180
R01 · FY2004 · HD
Pathogenesis of Mother to Child Transmission of HIV$348,401
R01 · FY2003 · HD
Pathogenesis of Mother to Child Transmission of HIV$363,535
R01 · FY2002 · HD
CORE--SCID-HU MOUSE$0
P30 · FY2002 · AI
HIV RESISTANCE AND RECOMBINATION IN SCID-HU MICE$194,668
R01 · FY2001 · AI
CORE--SCID-HU MOUSE$0
P30 · FY2001 · AI
CORE--SCID-HU MOUSE$0
P30 · FY2001 · AI
HIV RESISTANCE AND RECOMBINATION IN SCID-HU MICE$188,998
R01 · FY2000 · AI
CORE--SCID-HU MOUSE$142,758
P30 · FY2000 · AI